AI summary not available. Read the source abstract on PubMed.
Chronic pain
Research from anesthesiology, pain and critical care journals, sourced from PubMed.
Sorted by publication date, not import date. Recent filters exclude papers with only a publication year; find those under All years.
AI-generated abstract summaries can contain errors. Verify findings against the original paper before applying them to patient care.
Last successful paper check: 16 Nov 2026 17:18 UTC.
0 newly discovered papers saved; these are not necessarily published today.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
- Systematic review and meta-analysis of 10 randomized or quasi-randomized trials (6 facet, 4 SIJ) enrolling 392 patients comparing PRP with corticosteroid injections.
- Intra- or peri-articular PRP was compared with corticosteroids, with pain scored 0-10 as the primary outcome and disability (ODI or MODQ) as the secondary outcome.
- At 3 months PRP lowered pain scores more than corticosteroids (MD -1.32, 95% CI -2.14 to -0.50; P = .0015), with the difference persisting at 6 months.
- Disability showed no significant difference at 3 months, and the authors judge the certainty of evidence limited, calling for larger trials with standardized PRP protocols.
- A cross-sectional study of 208 adults with cancer pain in a hospital-based palliative care setting used Neurometer quantitative sensory testing.
- Patients were grouped by opioid use and compared on current perception and pain thresholds for Aβ, Aδ, and C fibers, with age-adjusted analyses.
- Pain thresholds did not differ between groups, adjusted or unadjusted, and after age adjustment only Aβ current perception threshold differed significantly.
- The authors concluded that routine opioid use was not associated with clinically meaningful threshold changes, while cautioning about the cross-sectional design and residual confounding.
- This retrospective analysis of NRMP and ERAS data covers 2019-2025 pain medicine fellowship cycles, with total applicants falling from 520 to 442.
- Anesthesiology applicants dropped 70%, from 351 to 106, while physical medicine and rehabilitation applicants rose 68%, from 101 to 170.
- Positions were stable (389 to 390 from 2024 to 2025), and fill rate showed a trend toward improvement, from 82.3% to 85.4%, with regional disparities.
- The authors attribute the shift to anesthesiology workforce dynamics and reimbursement concerns and call for early exposure, mentorship, and curriculum adaptation.
- Retrospective cohort study using VA Corporate Data Warehouse records of 30,462 veterans diagnosed with fibromyalgia, with comparisons of women and men.
- Nine co-occurring chronic overlapping pain conditions and use of nonpharmacological and pharmacological fibromyalgia treatments were compared by sex using logistic regression, unadjusted and adjusted.
- Women had higher adjusted odds of a co-occurring pain condition (aOR 1.17, 95% CI 1.11-1.23) and of multimodal treatment (aOR 1.29, 95% CI 1.19-1.40), but multimodal engagement was 9% to 12% overall.
- Women were also more often prescribed cyclobenzaprine and less often pregabalin, and the authors conclude that receipt of nonpharmacological treatments was low in both sexes.
- This qualitative study interviewed 46 adolescents aged 11-21 at one and three months after common surgeries, focusing on those still using opioids in weeks 3-4 after severe pain resolved.
- Participants' experiences were analyzed without a comparator, examining how preoperative clinic conversations and recovery guidance shaped their postoperative course.
- Positive experiences included normalized anxiety, recognizing recovery milestones, and effective non-opioid and non-pharmacologic options like ice and stretching; prolonged opioid users described greater fears and caregiver-directed pain management.
- The authors conclude that realistic preoperative recovery descriptions, encouraging engagement, and education on opioid and non-opioid options, including when to stop opioids, may protect against prolonged use.
- Retrospective cohort of 1,093 chronic pain patients treated with IV lidocaine at one Israeli hospital pain clinic from 2014 to 2022, covering 15,820 infusions.
- Serious adverse outcomes were defined as emergency department visits within 14 days of infusion; predictors included cardiovascular disease, prior stroke, diabetes and cumulative infusion count.
- Fifty-five patients (5.0%) had serious adverse outcomes; more than 50 cumulative infusions was the strongest predictor (OR 12.58, P<.001), while per-infusion risk stayed stable (OR 1.00, P=.854).
- In a refined analysis limited to plausibly lidocaine-related events (n=30), pre-existing cardiovascular disease emerged as a predictor (OR 3.88, P=.008), and the authors suggest enhanced cardiac monitoring for these patients.
- This is a theoretical framework paper, not an empirical study, and it reports no sample size, data, or measured outcomes.
- It proposes a generative model that links inferred threat to action policies, so pain intensity and pain behavior can be studied within one inferential loop.
- It argues chronic pain can persist when threat beliefs stay overly influential despite corrective evidence, and it uses placebo/nocebo and phantom pain as illustrations.
- The authors outline candidate measurements and falsifiable predictions centered on a cingulate-insula hub and descending control circuitry, and suggest stratifying patients by dominant mechanism.
- This commentary responds to the NIH HEAL pain research priorities report, which lists ten research priorities and five core principles.
- It focuses on Core Principle #1, which calls for including people with lived experience of pain at all stages of research, from planning to dissemination.
- The authors offer practical context for researchers starting to involve people with lived pain experience and describe how these people were included in the HEAL planning process.
- This descriptive qualitative study used semi-structured face-to-face interviews with 29 adults with low back pain, analysed by inductive reflexive thematic analysis.
- Participants were asked how they relate physical activity, stress and sleep to their pain flares, without a comparator or intervention.
- Perceived links varied widely, from no connection to complex interactions; activity was seen as either protective or provocative depending on intensity, type and context.
- Stress was perceived as an indirect link via routine, tension and awareness, and sleep as uncertain or clearly disruptive; authors note beliefs often diverged from current evidence and call for tailored education.
- A retrospective institutional cohort of 52 patients with chronic non-malignant abdominal pain treated with splanchnic RFA.
- Pain scores, opioid use and nausea were tracked at baseline and at 1, 6 and 12 months after RFA, with no comparator group.
- Mean VAS fell from 8.44 cm at baseline to 4.4 cm at 12 months, and opioid use significantly decreased at 12 months (p < 0.001).
- The authors concluded that most patients had long-term benefit, nausea days also fell at 6 months (p = 0.001), and mild adverse events were rare.
- This systematic review and meta-analysis pooled 27 studies (n = 4019) on experimentally induced or clinical pain lasting under 3 months and its effect on proprioception.
- Proprioceptive outcomes included joint position reproduction, motion detection thresholds, force matching, velocity detection, and left/right judgement tasks, with only the judgement task pooled statistically.
- On the left/right judgement task, people with acute clinical pain were less accurate for the affected side (MD -8.64, 95% CI -16.93 to -0.34), with no change in response time.
- Other outcomes showed position and movement sense impairments that varied by joint and angle, and the authors suggest acute pain may also disrupt somatotopic body representations.
- Cadaveric study of ten native and ten prosthetic knee capsules, sampling five genicular nerve target regions with histologic and immunohistochemical analysis.
- Compared intracapsular nerve ending and vascular densities between native and prosthetic knees; no clinical treatment was tested.
- Native knees had higher free nerve ending density (p < 0.001), while prosthetic knees had greater vascular density (p = 0.001) and more Pacini, Golgi and unclassified endings.
- FNE-vascular correlation was modest in native knees (r = 0.41) and negligible in prosthetic knees (r = 0.09); the authors suggest dense FNEs support nerve-targeted OA pain treatment.
- This preclinical rat study compared male and female rats subjected to chronic restraint stress, assessing tactile allodynia and spinal neurotrophin signaling.
- Investigators used intrathecal BDNF with receptor antagonists (THX-B for p75NTR, ANA-12 for TrkB), minocycline, and the KCC2 activator CLP257 to probe the pathway.
- Stress raised spinal BDNF in both sexes, more so in males, and the dominant route differed by sex: TrkB in males and p75NTR in females.
- The authors conclude that stress-induced allodynia runs through sex-specific BDNF receptor pathways, with KCC2 dysfunction contributing in both sexes; gonadectomy and hormone replacement experiments support a role for sex hormones.
- This prospective observational secondary analysis followed 231 adults with chronic pain (77.9% women) across four waves about three months apart, yielding 2309 provider ratings.
- Participants rated empathy for every provider consulted in the preceding three months, and multilevel models separated between-person from within-person empathy.
- Perceived empathy differed by provider type, with psychologists rated highest and orthopedists and rheumatologists lowest; mean empathy did not differ significantly by patient gender.
- Empathy at both levels was positively associated with treatment satisfaction, and men showed larger satisfaction drops than women at lower empathy levels.
AI summary not available. Read the source abstract on PubMed.
- Systematic review of 105 studies (111 publications) on evaluating and treating acute low back pain under 6 weeks, to inform a clinical guideline.
- Comparisons spanned imaging, drugs such as NSAIDs, opioids and steroids, nonpharmacologic options, and physical therapy referral, mostly against placebo, sham, or usual care.
- Moderate confidence in benefit at one or more time points for NSAIDs, manipulation, acupuncture, muscle relaxants, activity advice, and early physical therapy; effects were generally small.
- Psychosocial factors best predicted persistent low back pain, while few red-flag factors were highly informative for ruling serious pathology in or out.
- Cross-sectional analysis of 4961 Australian young adults aged 18-21 from two waves of the Longitudinal Study of Australian Children.
- Neurodivergence was defined by self-reported autism and/or ADHD and compared with neurotypical peers; no intervention was studied.
- Recurrent pain was reported by 38% of neurodivergent versus 27% of neurotypical young adults, and neurodivergent adults with pain missed a mean of 19.6 school or work days per year.
- The authors conclude that neurodivergence and recurrent pain compound emotional, physical and educational burden, calling for better recognition and tailored support.
- In a 7-day home study of 21 adults with chronic musculoskeletal pain, wrist actigraphy was compared with a wearable EEG headband and sleep diaries.
- Actigraphy was benchmarked against wearable EEG, with Bland-Altman limits of agreement and epoch-by-epoch sensitivity and specificity used to assess agreement.
- Actigraphy showed wide limits of agreement for all sleep variables, including total sleep time (bias 1.79 min; LoA -122.02 to 125.60 min), with sensitivity 92.8%, specificity 49.7%, and κ = 0.42.
- The authors conclude actigraphy should be interpreted cautiously as a surrogate for EEG-based sleep assessment, especially for wakefulness, fragmentation, and night-to-night variability.
- Randomized crossover study of 60 healthy women (mean age 25.13) exposed to capsaicin-induced acute thermal pain across two virtual reality sessions.
- The experimental arm received VR-based Interoceptive Modeling, compared with a control arm receiving VR pain visualization without the interoceptive modeling component, separated by a one-week washout.
- Pain intensity was lower in the experimental condition (Mdiff=5.30, 95% CI 0.34-10.27, p=.037), and immediate post-intervention RMSSD was higher (Mdiff=6.97, 95% CI 3.12-10.83, p<.001).
- The authors describe Interoceptive Modeling as a promising non-pharmacological approach but state that further research is needed.
- Prospective pre- and post-trial questionnaire study of 67 enrolled patients undergoing spinal cord stimulator trials, with 51 completing follow-up.
- Patients completed validated measures of centralized pain and related features (e.g., CSI, fibromyalgianess, PainDETECT) before the SCS trial and within 48 hours of its removal.
- Average and worst pain severity improved significantly after the trial (p < 0.001). Responders had lower fibromyalgianess (p = 0.03), CSI scores (p = 0.02), and widespread pain (p = 0.03).
- The authors conclude that greater centralized pain features were linked to less analgesic benefit, and that pre-procedural pain phenotyping may improve patient selection.
- Repeated-measures observational study of 382 urologic chronic pain patients, each imaged 2 to 4 times over 36 months.
- Resting intrinsic connectivity was recorded before and after a naturalistic challenge meant to provoke symptomatic pain and discomfort.
- Linear mixed-effects models linked current pain to sensory-discriminative network connectivity, and past-week recalled pain to distributed memory, salience, and affective regions; no effect sizes are given in the abstract.
- The authors conclude that different brain regions relate to different dimensions of chronic pain, supporting a dynamic model of its neural correlates.
- Study 1 was a meta-analysis of 67 studies (6,899 patients and controls), and Study 2 was a cross-sectional analysis of UK Biobank data (37,139 participants with chronic pain and controls).
- Study 2 used a predictive model of cognitive age to compare chronic pain with neurological and psychiatric conditions, with healthy controls as the reference group.
- The meta-analysis found moderate cognitive deficits in chronic pain (g = -0.48, 95% CI -0.52 to -0.43, I² = 82.03), while UK Biobank effects were smaller (d = 0.04-0.30).
- Participants with 4 or more pain sites showed an advanced cognitive age pattern, and the authors suggest further clinical evaluation if impairment seems disproportionate to pain severity.
- This systematic review pooled prospective randomized trials and observational studies of preoperative genicular nerve radiofrequency ablation before total knee arthroplasty.
- The comparison was ablation against control procedures, assessing function, pain, opioid use, length of stay, and complications.
- Trials showed no meaningful improvement in medium- to long-term function, acute pain, or length of stay, and no clear rise in complications was found.
- Retrospective data hinted at fewer long-term opioid refills, but no study stratified outcomes by baseline risk, so high-risk patients remain untested.
- This study combined a human cohort of post-traumatic headache patients without prior aura with a mouse model of mild TBI, using electrophysiology, neuroimaging, and behavioral assays.
- Mice received closed-head mTBI, and separately onabotulinumtoxinA was given subcutaneously to the scalp after injury, with optogenetically evoked CSD used to probe pain behavior.
- In humans, 35 of 108 patients (32%) developed new aura within 60 days, and injured mice showed a 160% increase in CSD induction probability.
- OnabotulinumtoxinA did not change CSD susceptibility but completely abolished optogenetic CSD-induced allodynia, which the authors suggest may help treat PTH with aura.
AI summary not available. Read the source abstract on PubMed.
AI summary not available. Read the source abstract on PubMed.
- This case report describes one patient with metastatic lung adenocarcinoma and refractory pain from a pathologic humeral fracture, hospitalized for treatment.
- Temporary percutaneous brachial plexus peripheral nerve stimulation was placed using a dual-lead, ultrasound-guided, parallel subclavicular technique called DAVIS.
- The patient stopped all opioid use and reported substantial, sustained pain relief after implantation; no numerical pain or opioid measures are reported in the abstract.
- The authors conclude brachial plexus PNS is promising for extremity oncologic pain and that dual-lead parallel placement may help in anatomically complex or opioid-refractory cases.
- This PRISMA-ScR scoping review of 199 studies (2010 to August 2025) mapped weight-loss strategies in adults with obesity and hip or knee osteoarthritis.
- Of the included studies, 36 (18.1%) directly assessed GLP-1 receptor agonists, and only 14 of those reported original data.
- Most GLP-1 studies (29/36) were published in 2024–2025, and 19/36 were level 5 evidence; knee data showed weight loss and pain/function gains, while hip data were sparse.
- The authors call GLP-1 receptor agonists a promising adjunct and advise using them within supervised, multimodal musculoskeletal care rather than as standalone weight-loss agents.
- Retrospective single-center cohort of 1,025 consecutive knees with symptomatic knee osteoarthritis treated between June 2024 and June 2026.
- All knees received ultrasound-guided cooled radiofrequency ablation using the MDNT technique, which adds physiological confirmation before ablation; there was no comparator group.
- Mean NRS pain fell from 7.76 to 2.46 by postoperative day 1 (mean reduction 5.29; 95% CI 5.16-5.43; P < 0.001) among 1,021 knees with early data.
- Repeat CRFA occurred in 8 of 1,025 knees (0.8%), and repeat-CRFA-free survival was 99.8% at 12 months; the authors call the findings hypothesis-generating.
- Multicenter retrospective cohort study reviewing charts of 1,145 patients who underwent basivertebral nerve ablation for vertebrogenic low back pain.
- Single exposure with no comparator group: intraosseous radiofrequency ablation of the basivertebral nerve, with complications categorized from chart notes.
- The overall complication rate was 3.2% (37 events), and the most common was increased radicular pain at 2.2% (25), which resolved in all but one patient.
- Excluding transient radicular pain (24 cases), the complication rate fell to 1.1% (13), and the authors conclude the procedure is safe in real-world settings.
- A retrospective chart review of 31 patients who received 38 conventional genicular nerve RFAs at an academic medical center from 2016 to 2023.
- Conventional radiofrequency ablation of three genicular nerves using two-tined electrodes, in patients with a prior positive genicular nerve block; no comparator group was reported.
- Mean NRS reduction was -3.17 at 0-3 months, -1.31 at 3-6 months, and -1.92 at 6-12 months, and half of patients kept an MCID-level reduction for 11.17 months (95% CI: 7.29, 13.40).
- PROMIS Physical Health, PROMIS Mental Health, and PHQ-9 showed no statistically significant change, and a history of depression was associated with treatment failure.
AI summary not available. Read the source abstract on PubMed.
- Prospective AURORA cohort of 2834 emergency department trauma survivors, enrolled within 72 hours of injury, followed with smartphone surveys to one year.
- Group-based trajectory modelling identified 5 pain, 6 sleep discontinuity and 5 hyperarousal trajectories, plus 6 joint multitrajectory profiles in 1800 participants.
- Persistently high pain occurred in 35.1% of participants, and baseline sleep discontinuity was strongly associated with persistent high pain (adjusted OR 3.31, 95% CI 2.61-4.18).
- Authors conclude that early sleep disruption, hyperarousal and pain are interconnected, and that targeting multiple domains may be a promising way to prevent chronic post-injury pain.
- Retrospective observational comparative-effectiveness cohort of 90 patients with moderate-to-severe knee osteoarthritis, followed for 24 months.
- Compared cooled genicular radiofrequency ablation alone (n=50) with the same ablation plus intra-articular botulinum toxin type A (n=40), with a planned repeat BoNT-A injection at about 12 months in the combination group.
- Significant treatment-by-time interactions were found for NRS (ß=-0.84, 95% CI -1.21 to -0.47; P=0.0002) and WOMAC (ß=-6.3, 95% CI -9.4 to -3.2; P=0.0003).
- At 24 months, responder rates were 86.5% with combination therapy versus 51.1% with ablation alone (P=0.0004); the authors call for randomized trials to confirm this.
- Cross-sectional imaging study of 26 classical trigeminal neuralgia patients and 14 healthy controls using a high-resolution, nerve-specific diffusion tensor imaging protocol.
- Four coronal regions of interest along the cisternal trigeminal nerve, from its brainstem root entry zone out to 5.4 mm distally, were compared between the affected and contralateral sides.
- On the affected side, FA was significantly reduced at 1.8 mm (p<0.01) and 3.6 mm (p<0.05) distal to the root entry zone versus controls and the contralateral nerve.
- Both nerves in patients showed a proximal-to-distal FA decline (p<0.0001) with rising RD, AD and MD, a gradient not consistently seen in controls; the authors suggest broader, possibly neuroinflammatory, processes.
- This scoping review synthesized 63 eligible studies on suicidality in people with chronic noncancer pain and co-occurring substance use or SUD, searched across five databases.
- The review charted the literature rather than testing an intervention, so it reports no pooled effect estimates or comparator results.
- Studies were mostly cross-sectional, community samples were underrepresented, and most were from the United States; five themes emerged, including untreated pain and stigma.
- The authors identified gaps in standardized suicidality assessment, rigorous study designs, and representative samples, and proposed future research directions.
- This two-stage adaptation study used established frameworks, combining an adaptation working group, evidence review, interest-holder engagement and expert consultation to adapt the RESOLVE program for chronic low back pain.
- Stage 2 used a structured consensus meeting to propose and finalise adaptations to the intervention's content, delivery, resources and clinician training.
- The consensus process finalised 8 adaptations that refine and streamline existing RESOLVE components rather than removing or adding whole elements.
- The authors present the approach as practical guidance for adapting RESOLVE and other complex treatments for clinical implementation, though the adapted program's effects were not reported.
AI summary not available. Read the source abstract on PubMed.
- Qualitative needs assessment using an online survey and semi-structured interviews with 15 patients/families and 15 multidisciplinary health professionals.
- Participants reflected on their experiences of virtual versus in-person pediatric chronic pain care, with purposive sampling of racialized patients and those with complex needs or neurodevelopmental disabilities.
- Patient and family themes covered individual needs, navigating healthcare, and partnership in a paternalistic system, while clinicians emphasized clinical needs, engagement, values, and context.
- The authors found that patient and clinician perspectives differed and concluded that more evidence is needed to support shared decisions about care delivery mode.